search
Back to results

OPTIFIT-Optimal Fiber Trial for Diabetes Prevention

Primary Purpose

Diabetes, Nutrition Disorders, Obesity

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Fiber
Placebo
Sponsored by
German Institute of Human Nutrition
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diabetes focused on measuring Nutritional support, Diet therapy, Diabetes prevention, Insoluble fiber, Healthy life style, Weight loss

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Impaired glucose tolerance
  • Age>18years old
  • both gender

Exclusion Criteria:

  • Diabetes type 1 and type 2
  • chronic or malignant disease
  • Intake of metabolic influence drugs
  • Food allergies, fiber intolerance

Sites / Locations

  • German Instiute of Human Nutrition
  • Charite University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Drink enriched in fibers

Placebo drink

Arm Description

7,5g enriched fiber drinks, BID

Placebo drink, BID

Outcomes

Primary Outcome Measures

Change of 2h-postprandial blood glucose from IGT to diabetes mellitus type 2 or normal glucose tolerance (NGT)
Change of the glucose metabolism (OGTT)

Secondary Outcome Measures

Change of insulin sensitivity
Measurement by HOMA and OGIS from the OGTT
Change of insulin secretion
Measurement by the OGTT
Expression of inflammatory markers in blood
CRP, leukocytes, adipocytokines
Biometric data
Nutritional impact of blood pressure, anthropometry (body weight and body composition)
Assessment of cognitive performance
Development of indices for the prediction of fat mass
Change of fat fraction in liver, abdominal and in the total body fat measuring by MRI/H1-spectroscopy
Determination of gene expression in adipose tissue
Determination of inflammatory and other transcripts in sc adipose tissue in a fat biopsy.

Full Information

First Posted
September 5, 2012
Last Updated
February 4, 2015
Sponsor
German Institute of Human Nutrition
Collaborators
Charite University, Berlin, Germany, German Diabetes Foundation, Munich, Germany, Ernst von Bergmann Hospital, University Hospital Tuebingen
search

1. Study Identification

Unique Protocol Identification Number
NCT01681173
Brief Title
OPTIFIT-Optimal Fiber Trial for Diabetes Prevention
Official Title
Investigation of the Effect of Insoluble Dietary Fiber on Carbohydrate and Lipid Metabolism and the Prevention of Diabetes Mellitus Type 2 in Subjects With Impaired Glucose Tolerance
Study Type
Interventional

2. Study Status

Record Verification Date
February 2015
Overall Recruitment Status
Completed
Study Start Date
May 2010 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
German Institute of Human Nutrition
Collaborators
Charite University, Berlin, Germany, German Diabetes Foundation, Munich, Germany, Ernst von Bergmann Hospital, University Hospital Tuebingen

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
High intake of insoluble fiber is strongly associated with a reduced incidence of diabetes and cardiovascular events in prospective observation studies. Our primary objective is to compare a life style diabetes prevention program(PRAEDIAS) with and without added insoluble fibers in its effectiveness to prevent incident diabetes type 2 in high risk individuals with impaired glucose tolerance. Subjects with IGT not willing to participate in the intervention will be used as independent controls. Secondary aims are to identify mechanisms of action with regard to body composition, anti-inflammatory and metabolic effects of fibers. We propose a randomized, prospective intervention study. The results will be of general relevance for guidance of fiber intake in the population and will help the food industry to design healthy high fiber foods. Fiber can be added at low cost to numerous foods. Increased fiber intake may therefore provide a simple non-cognitive prevention strategy effective at the population level.
Detailed Description
The overall objective is to investigate whether insoluble fibers added to standard nutrition can reduce the progression of impairment of glucose metabolism in a high risk population with impaired glucose metabolism. Large prospective cohort studies clearly show that mainly insoluble cereal fiber from whole grains is associated with reduced risk of type 2 diabetes and cardiovascular disease. However, there is a lack of evidence from prospective intervention studies targeted to evaluate the potential of dietary fibers to reduce diabetes and cardiovascular disease as recently stated by the Cochrane Foundation. Dietary fiber intake is generally much lower than currently recommended, which may in part be related to side effects of whole grain nutrients and their gustatory properties. Intestinally uncomfortable effects are at least partly related to fermentation which is much less induced by insoluble non-fermentable fibers than by soluble fermentable fibers. The prospective demonstration of beneficial effects of insoluble fibers in preventing diabetes type 2 will allow detailed nutritional recommendations. This may serve to support the consumption of metabolically beneficial constituents of fiber-rich diets and help to increase fiber intake by high fiber natural nutrients or everyday nutrients enriched in insoluble natural fibers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Nutrition Disorders, Obesity, Overweight, Metabolic Syndrome x, Body Weight, Glucose Metabolism Disorders, Metabolic Diseases
Keywords
Nutritional support, Diet therapy, Diabetes prevention, Insoluble fiber, Healthy life style, Weight loss

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Drink enriched in fibers
Arm Type
Experimental
Arm Description
7,5g enriched fiber drinks, BID
Arm Title
Placebo drink
Arm Type
Experimental
Arm Description
Placebo drink, BID
Intervention Type
Dietary Supplement
Intervention Name(s)
Fiber
Intervention Description
200ml drinks enriched with 7,5g of fiber (90% insoluble fiber, 10% soluble fiber), BID, over 24 months
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
200ml Placebo, BID, over 24 months
Primary Outcome Measure Information:
Title
Change of 2h-postprandial blood glucose from IGT to diabetes mellitus type 2 or normal glucose tolerance (NGT)
Description
Change of the glucose metabolism (OGTT)
Time Frame
0, 12, 24 months
Secondary Outcome Measure Information:
Title
Change of insulin sensitivity
Description
Measurement by HOMA and OGIS from the OGTT
Time Frame
0, 12, 24 months
Title
Change of insulin secretion
Description
Measurement by the OGTT
Time Frame
0, 12, 24 months
Title
Expression of inflammatory markers in blood
Description
CRP, leukocytes, adipocytokines
Time Frame
0, 6, 12, 18, 24 months
Title
Biometric data
Description
Nutritional impact of blood pressure, anthropometry (body weight and body composition)
Time Frame
0, 6, 12, 18, 24 months
Title
Assessment of cognitive performance
Time Frame
0, 12, 24 months
Title
Development of indices for the prediction of fat mass
Description
Change of fat fraction in liver, abdominal and in the total body fat measuring by MRI/H1-spectroscopy
Time Frame
0, 12, 24 months
Title
Determination of gene expression in adipose tissue
Description
Determination of inflammatory and other transcripts in sc adipose tissue in a fat biopsy.
Time Frame
0, 12, 24 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Impaired glucose tolerance Age>18years old both gender Exclusion Criteria: Diabetes type 1 and type 2 chronic or malignant disease Intake of metabolic influence drugs Food allergies, fiber intolerance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreas FH Pfeiffer, Prof.
Organizational Affiliation
German Institute of Human Nutrition Potsdam-Rehbruecke
Official's Role
Principal Investigator
Facility Information:
Facility Name
German Instiute of Human Nutrition
City
Potsdam-Rehbruecke
State/Province
Nuthetal
ZIP/Postal Code
14558
Country
Germany
Facility Name
Charite University
City
Berlin
ZIP/Postal Code
12200
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
29492637
Citation
Honsek C, Kabisch S, Kemper M, Gerbracht C, Arafat AM, Birkenfeld AL, Dambeck U, Osterhoff MA, Weickert MO, Pfeiffer AFH. Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT). Diabetologia. 2018 Jun;61(6):1295-1305. doi: 10.1007/s00125-018-4582-6. Epub 2018 Feb 28.
Results Reference
derived

Learn more about this trial

OPTIFIT-Optimal Fiber Trial for Diabetes Prevention

We'll reach out to this number within 24 hrs